Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe (COVID-19) First published 25/11/2021 Last updated 11/07/2025 EU PAS number:EUPAS44273 Study Finalised